|
Name of the service |
Unit |
Price KZT |
|
Allergy diagnostics |
||
|
CDL - Allergens domestic/molecular (А) |
||
|
СDL - Domestic/molecular allergens (A) |
1 test |
5 460 |
|
СDL - Fungal allergens (D) |
1 test |
5 460 |
|
СDL - Tree allergens (T) |
1 test |
5 460 |
|
СDL - Domestic dust allergens (H) |
1 test |
5 460 |
|
СDL - Animal allergens (E) |
1 test |
5 460 |
|
СDL - Inhalant allergens (IP) |
1 test |
5 460 |
|
СDL - Drug allergens © |
1 test |
5 460 |
|
СDL - Insect allergens (I) |
1 test |
5 460 |
|
СDL - Parasitic allergens (P) |
1 test |
5 460 |
|
СDL - Food-based allergens (F) |
1 test |
5 460 |
|
СDL - Musty allergens (M) |
1 test |
5 460 |
|
СDL - Professional allergens (K) |
1 test |
5 460 |
|
СDL - Other allergens (O) |
1 test |
5 460 |
|
СDL - Weed allergens (W) |
1 test |
5 460 |
|
СDL - Allergens of grasses and grains (G) |
1 test |
5 460 |
|
Biochemical screens |
||
|
Biochemical blood tests. Protein metabolism |
||
|
Albumen |
1 test |
1 950 |
|
Bence Jones protein in urine |
1 test |
46 735 |
|
Protein immunotyping (M-gradient) |
1 test |
40 950 |
|
Creatinine |
1 test |
2 080 |
|
Uric acid |
1 test |
2 080 |
|
Urea |
1 test |
2 080 |
|
Total protein |
1 test |
2 080 |
|
Blood protein electrophoresis (Protein fractions) |
1 test |
7 540 |
|
Biochemical blood tests. Iron metabolism |
||
|
Transferrin |
1 test |
3 575 |
|
Ferritin |
1 test |
4 810 |
|
Total Iron-Binding Capacity (TIBS) |
1 test |
4 420 |
|
Biochemical blood tests. Lipoprotein metabolism |
||
|
Apolipoprotein A (Apo-A) |
1 test |
4 550 |
|
Apolipoprotein B (Apo-B) |
1 test |
5 200 |
|
High density lipoproteins (HDL) |
1 test |
3 055 |
|
Low-density lipoproteins (LDL) |
1 test |
2 470 |
|
Triglycerides (TG) |
1 test |
2 080 |
|
Cholesterol (CS) |
1 test |
2 080 |
| Lipoprotein(a) | 1 test | 6 305 |
|
Biochemical blood tests. Pigment metabolism |
||
|
Total bilirubin |
1 test |
2 340 |
|
Conjugated bilirubin |
1 test |
2 340 |
|
Biochemical blood tests. Carbohydrate metabolism |
||
|
Glycosylated hemoglobin (Hemoglobin A1c, HbA1c) |
1 test |
4 810 |
|
Glucose |
1 test |
2 210 |
|
Glucose on the glucometer |
1 test |
585 |
|
Biochemical blood tests. Enzymes |
||
|
Alanine aminotransferase (ALT) |
1 test |
2 470 |
|
Alpha amylase |
1 test |
2 600 |
|
Pancreatic amylase |
1 test |
4 550 |
|
Aspartate aminotransferase (AST) |
1 test |
2 470 |
|
Gamma glutamyl transferase (GGTP) |
1 test |
3 315 |
|
Creatinine kinase-MB fraction (CFK-MB) |
1 test |
3 445 |
|
Creatine phosphokinase (CPK) |
1 test |
2 470 |
|
Lactate dehydrogenase (LDH) |
1 test |
2 730 |
|
Alkaline phosphatase (ALP) |
1 test |
2 340 |
|
Lipase |
1 test |
3 445 |
|
Biochemical urine tests |
||
|
Glucose in a single urine portion |
1 test |
1 885 |
|
Glucose in daily urine |
1 test |
2 015 |
|
Urine Ca++ |
1 test |
1 950 |
|
Urine creatinine |
1 test |
1 690 |
|
Urine Mg++ |
1 test |
1 690 |
|
Urine uric acid |
1 test |
1 690 |
|
Urine urea |
1 test |
1 820 |
|
Microalbumin complex (Creatinine/albumin ratio) |
1 test |
11 375 |
|
Relative indices of metabolic disorders (ratio calcium/creatinine, magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine |
1 test |
5 655 |
|
Relative index of metabolic disorders (calcium/creatinine ratio) |
1 test |
3 965 |
|
Relative index of metabolic disorders (magnesium/creatinine ratio) |
1 test |
4 290 |
|
Relative index of metabolic disorders (inorganic uric acid/creatinine ratio) |
1 test |
3 705 |
|
Relative index of metabolic disorders (inorganic phosphorus/creatinine ratio) |
1 test |
3 575 |
|
Rehberg test |
1 test |
4 095 |
|
Glomerular filtration rate |
1 test |
3 315 |
|
Urine osmolarity |
1 test |
845 |
|
Urine phosphorus |
1 test |
1 365 |
|
Urine potassium |
1 test |
1 365 |
|
Sodium urine |
1 test |
1 365 |
|
Chloride urine |
1 test |
1 365 |
|
Biochemistry |
||
|
Blood osmolarity |
1 test |
2 080 |
|
Immune status |
||
|
Immunoglobulin A |
1 test |
4 680 |
|
Immunoglobulin G |
1 test |
4 680 |
|
Immunoglobulin M |
1 test |
4 680 |
|
Complement C3 |
1 test |
4 420 |
|
Complement C4 |
1 test |
4 420 |
|
Hemostatic system testings |
||
|
Thrombocyte aggregation with P2Y (PFA 200 analyzer) |
1 test |
31 850 |
|
Thrombocyte aggregation with ADF (PFA 200 analyzer) |
1 test |
31 850 |
|
Thrombocyte aggregation with Epinephrine (PFA 200 analyzer) |
1 test |
30 030 |
|
Activated partial/batch thromboplastin time (APTT/ABTT) |
1 test |
2 080 |
|
Antithrombin III (AT-3) |
1 test |
5 785 |
|
Lupus anticoagulant (Lupus test) |
1 test |
8 645 |
|
Duke bleeding time |
1 test |
1 365 |
|
Clotting time according to Sukharev |
1 test |
1 365 |
|
D-Dimer Exclusion quantification |
1 test |
11 245 |
|
D-dimer (by turbidimetric immunoassay), quantification |
1 test |
13 650 |
|
Coagulogram - complex No. 1 (APTT, INR, PT, PTI, fibrinogen, TT) |
1 test |
5 460 |
|
Coagulogram - complex No. 2 (APTT, INR, PT, PTI, fibrinogen, TT+ SFMC) |
1 test |
7 540 |
|
International normalized ratio (INR) |
1 test |
2 730 |
|
Protein С |
1 test |
14 365 |
|
Prothrombin time (PT) |
1 test |
2 210 |
|
Prothrombin index (PTI) |
1 test |
2 210 |
|
Soluble fibrin-monomer complexes (SFMC) |
1 test |
2 080 |
|
C1 inhibitor |
1 test |
16 380 |
|
Thrombin time (TT) |
1 test |
2 210 |
|
Thromboelastogram with heparinase |
1 test |
15 990 |
|
Thromboelastogram with kaolin |
1 test |
21 190 |
|
Fibrinogen |
1 test |
2 080 |
|
INR/PT/Quick value in capillary blood |
1 test |
10 920 |
|
Specific proteins |
||
|
Alpha - 1 - antitrypsin |
1 test |
6 565 |
|
Antistreptolysin O (ASL-O) quantification |
1 test |
3 835 |
|
Haptoglobin |
1 test |
2 210 |
|
Myoglobin quantification |
1 test |
2 990 |
|
Rheumatoid factor (RF), quantification |
1 test |
3 380 |
|
C-reactive protein (CRP) quantitation |
1 test |
3 315 |
|
Ceruloplasmin |
1 test |
5 590 |
|
Electrolytes, mineral metabolism |
||
|
Antibodies to TSH receptors (anti-TSHr, TSH receptor antibodies, a-rTSH) |
1 test |
11 765 |
|
Ionized calcium |
1 test |
4 550 |
|
Serum iron (Fe) |
1 test |
2 470 |
|
Potassium |
1 test |
1 365 |
|
Total calcium (Ca) |
1 test |
2 080 |
|
Acid-base state (ABS) of blood (Blood gases) |
1 test |
7 410 |
|
Magnesium (Mg) |
1 test |
2 210 |
|
Copper (Cu) |
1 test |
1 755 |
|
Sodium |
1 test |
2 080 |
|
Organic phosphorus (P) |
1 test |
2 340 |
|
Chlorine |
1 test |
2 080 |
|
Electrolytes (potassium, sodium, ionized calcium, chlorine) in blood serum |
1 test |
6 175 |
|
Acid-base state of blood, on a portable analyzer of gases, electrolytes and blood metabolites |
1 test |
13 650 |
|
Hematological tests |
||
|
LE-phenomenon (LE - cells, lupus cells) |
1 test |
4 095 |
|
Blood test for malarial plasmodium using the “thin smear” and “thick smear” method |
1 test |
1 755 |
|
CBC+DIFF |
1 test |
3 055 |
|
CBC (short) (without WBC) |
1 test |
1 690 |
|
Reticulocyte count |
1 test |
1 690 |
|
Thrombocyte count according to Fonio |
1 test |
1 690 |
|
Immune status |
||
|
Indicators of cellular immunity (L/cytes; T-l/cytes-CD3+; T-helper cells-CD3.4+; T-cytotoxic - CD3.8+; B-l/cytes CD3-.19+; Natural killer cells - CD3 -,16,56+) |
1 test |
25 935 |
|
Phagocytosis (oxygen-independent) |
1 test |
14 365 |
|
Immunology research |
||
|
Vitamins |
||
|
Vitamin D total, 25-OH-VitD |
1 test |
10 010 |
|
Vitamin D3, 25-OH-VitD3 |
1 test |
9 295 |
|
Vitamin B12, Cyanocobalamin |
1 test |
5 460 |
|
Active Vitamin B12, Holotranscobalamin |
1 test |
8 775 |
|
Folic acid (Folate) |
1 test |
4 940 |
|
Gastropanel BIOHIT |
||
|
Immunological characteristics of the gastric mucosa (Gastropanel: pepsinogen I, pepsinogen II, gastrin-17B, gastrin-17S, Anti-Heli |
1 test |
31 395 |
|
Hormones of the pituitary-adrenal system in the blood |
||
|
Adrenocorticotropic hormone (ACTH) |
1 test |
6 565 |
|
Aldosterone |
1 test |
9 295 |
|
Growth hormone (Somatotropic hormone, hGH) |
1 test |
10 920 |
|
Dehydroepiandrosterone sulfate (DHEA-s) |
1 test |
6 825 |
|
Cortisol |
1 test |
5 460 |
|
Catecholamines (adrenaline, noradrenaline, dopamine) in blood plasma by ELISA |
1 test |
31 395 |
|
Melatonin in blood serum by ELISA method, quantitative determination |
1 test |
19 825 |
|
Hormones of the pituitary-adrenal system in the urine |
||
|
Adrenaline (epinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
19 825 |
|
Dopamine in blood serum by ELISA method, quantitative determination |
1 test |
19 825 |
|
Noradrenaline (norepinephrine) in blood serum by ELISA method, quantitative determination |
1 test |
19 825 |
|
Vanillyl mandelic acid in daily urine (VMA, 24h urine) |
1 test |
7 540 |
|
Homovanillic acid in daily urine (HVA, 24h urine) |
1 test |
7 540 |
|
Cortisol in daily urine (Cortisol, 24h urine) |
1 test |
6 695 |
|
Pancreatic hormones |
||
|
Insulin |
1 test |
6 175 |
|
Binding peptide (C-Peptide) |
1 test |
6 565 |
|
Reproductive system hormones |
||
|
Anti-Mullerian hormone, AMH, MIS |
1 test |
10 270 |
|
Sex hormone binding globulin (SHBG) |
1 test |
6 825 |
|
Luteinizing hormone (LH) |
1 test |
4 810 |
|
Progesterone |
1 test |
4 810 |
|
Prolactin |
1 test |
4 810 |
|
Testosterone |
1 test |
6 175 |
|
Follicle stimulating hormone (FSH) |
1 test |
4 420 |
|
Estradiol |
1 test |
4 290 |
|
Thyroid hormones |
||
|
Antibodies to thyroglobulin (Anti-Tg) |
1 test |
4 810 |
|
Antibodies to thyroid peroxidase (Anti-TPO) |
1 test |
5 330 |
|
Thyroglobulin (Tg) |
1 test |
5 785 |
|
Thyroid stimulating hormone (TSH) |
1 test |
4 810 |
|
Total thyroxine (total T4) |
1 test |
4 095 |
|
Free thyroxine (FT4) |
1 test |
4 420 |
|
Total triiodothyronine (total T3) |
1 test |
5 005 |
|
Free triiodothyronine (FT3) |
1 test |
4 940 |
|
Autoimmune pathology diagnostics (EIA, ECLIA) |
||
|
Antimitochondrial antibodies M2 subtype (AMA-M2) |
1 test |
10 010 |
|
Antineutrophil cytoplasmic antibodies screening (ANCA-screen) |
1 test |
10 270 |
|
Antinuclear antibodies screening (ANA screen) |
1 test |
9 295 |
|
Antinuclear antibodies screening (ANA-Detect) |
1 test |
9 295 |
|
Antibodies to GBM in blood serum by ELISA method |
1 test |
11 375 |
|
Antibodies to beta-2-glycoprotein I (Anti-ß-2 Glycoprotein) |
1 test |
9 165 |
|
Antibodies to double-stranded DNA (a-dsDNA) |
1 test |
9 295 |
|
Antibodies to single-stranded DNA (a-ssDNA) |
1 test |
9 295 |
|
Antibodies to gastric parietal cells (a-Parietal cell IgG) |
1 test |
9 295 |
|
Antibodies to tissue transglutaminase screening (a-tTG IgA,G) |
1 test |
9 295 |
|
Antibodies to elastase (Anti-Elastase) |
1 test |
9 295 |
|
Class A antibodies to Saccharomyces cerevisiae (ASCA IgA) |
1 test |
9 295 |
|
Class G antibodies to Saccharomyces cerevisiae (ASCA IgG) |
1 test |
9 295 |
|
Class G antibodies to histones (a-Histone IgG) |
1 test |
10 270 |
|
Class G antibodies to cardiolipin (A-Cardiolipin IgG) |
1 test |
10 270 |
|
Class G antibodies to modified citrullinated vimentin (A-MCV IgG) |
1 test |
11 245 |
|
Class G antiphospholipid antibodies (AFL IgG) |
1 test |
10 140 |
|
Class M antibodies to cardiolipin (A-Cardiolipin IgM) |
1 test |
10 140 |
|
Class M antiphospholipid antibodies (AFL IgM) |
1 test |
9 295 |
|
Anti-Prothrombin screening |
1 test |
9 295 |
|
Antibodies to insulin (A-insulin) |
1 test |
10 270 |
|
Total antibodies class A, M, G to cardiolipin, screening (A-Cardiolipin total) |
1 test |
9 295 |
|
Extractable nuclear antibodies, extensive assay (ENA combi) |
1 test |
29 770 |
|
Antineutrophil cytoplasmic antibodies, extensive assay (ANCA-combi) |
1 test |
46 150 |
|
Antinuclear antibodies, extensive analysis (ANA combi) |
1 test |
33 475 |
|
Antisperm antibodies (ASA) |
1 test |
15 015 |
|
IgG antibodies to cyclic citrullinated peptide (a-CCP) |
1 test |
20 800 |
|
Antibodies to insulin in blood serum by ELISA method, quantification |
1 test |
6 825 |
|
Extractable nuclear antibodies, screening (ENA screen) |
1 test |
8 905 |
|
"ANA pro" for semi-quantitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma |
1 test |
27 300 |
|
"ANCA Dot" for the qualitative determination of IgG antibodies to myeloperoxidase (MPO), proteinase 3 (PR-3) and glomerular basement membrane (GBM) in human serum and plasma |
1 test |
31 395 |
|
"ANA 12 LINE" for the qualitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma |
1 test |
34 125 |
|
Gliadin – IgG Reagent kit for quantitative enzyme immunoassay (ELISA) for the determination of IgG antibodies to gliadin in blood serum |
1 test |
14 365 |
|
Gliadin – IgA Reagent kit for enzyme immunoassay (ELISA) for the determination of IgA antibodies to gliadin in blood serum |
1 test |
14 365 |
|
Anti-Acetylcholine Receptor IgG (ELISA), Serum |
|
37 700 |
|
Autoimmune pathology diagnostics (LIA tests) |
||
|
Antibodies in autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM) |
1 test |
35 815 |
|
Antibodies in autoimmune liver diseases IMTEC-Liver-LIA S (IgG to AMA M2, Sp100, LKM1, gp210, LC1 and SLA) |
1 test |
18 460 |
|
Antinuclear antibodies ANA-LIA (IgG to nucleosomes, dsDNA, histones, SmD1, U1-snRNP, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0) |
1 test |
8 515 |
|
Antinuclear antibodies ANA-LIA MAXX: IgG to nucleosomes, dsDNA, histones, SmD1, PCNA, P0, SS-A/Ro60 and 52kD, SS–B/La, CENP-B, Scl-70, U1-snRNP, AMA M2, Jo-1, PM-Scl, Mi-2(β), Ku |
1 test |
37 700 |
|
Antibodies in autoimmune myositis IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP and Ku) |
1 test |
19 305 |
|
Antibodies for celiac disease IMTEC-Celiac Disease-LIA S (IgA and IgG to gliadin, tissue transglutaminase) |
1 test |
8 190 |
|
Antibodies in gastrointestinal diseases Gastro-LIA (IgA and IgG to gliadin, tTG, mannan, PCA, Castle factor) |
1 test |
25 675 |
|
HepAK 7 Plus Dot — Immunodot Assay for Qualitative Detection of IgG Antibodies to M2, LKM-1, LC-1, SLA, F-Actin, gp210, and sp100 in Human Serum or Plasma |
1 test |
39 000 |
|
Anti-Phospholipid 10 Dot (Immunodot), IgG/IgM to Phospholipids and β2-Glycoprotein I, Serum |
1 test |
84 500 |
|
ANA 18 Line — Immunodot Assay for Qualitative Detection of Autoantibodies to Nuclear and Cytoplasmic Antigens in Human Serum or Plasma |
1 test |
48 100 |
|
Anti-Ganglioside Dot — Immunodot Assay for Qualitative Detection of IgG or IgM Antibodies to Gangliosides in Human Serum |
1 test |
84 500 |
|
Autoimmune pathology diagnostics using indirect immunofluorescence (inDIF) |
||
|
Antikeratin antibodies (AKA) by indirect immunofluorescence (inDIF) |
1 test |
11 310 |
|
Antineutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence (inDIF) |
1 test |
8 320 |
|
Antinuclear factor on the HEp-2 cell line (ANF) by indirect immunofluorescence (inDIF) |
1 test |
11 310 |
|
Antibodies to native DNA (a-nDNA) by indirect immunofluorescence (inDIF) |
1 test |
11 310 |
|
Autoantibodies by the method (nRIF) on a triple substrate (LKM-1, Antibodies to gastric parietal cells, to smooth muscles (F-actin), ANF on the HEp-2 cell line, AMA-M1.9) |
1 test |
11 310 |
|
cANCA — Reagent Kit for the Detection of IgG Antibodies to Neutrophil Cytoplasmic Antigens (ANCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
26 000 |
|
pANCA — Reagent Kit for the Detection of IgG Antibodies to Neutrophil Cytoplasmic Antigens (ANCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
26 000 |
|
Triple — Reagent Kit for the Detection of Antibodies (ANA/AMA/ASMA/PCA) in Human Serum by Indirect Immunofluorescence (IIF) |
1 test |
28 600 |
|
nDNA — Reagent Kit for the Detection of IgG Antibodies to Native DNA in Human Serum |
1 test |
23 400 |
|
CeliAc — Reagent Kit for the Detection of IgA or IgG Antibodies to Endomysium, Tissue Transglutaminase 2 (tTG2), and Deamidated Gliadin in Human Serum |
1 test |
42 900 |
|
Anti-Aquaporin-4 — Indirect Immunofluorescence (IIF) Reagent Kit for the Detection of Antibodies to Aquaporin-4 in Human Serum |
1 test |
52 000 |
|
Anti-MOG — Immunofluorescence Assay for the Detection of Antibodies to Myelin Oligodendrocyte Glycoprotein (MOG) in Human Serum |
1 test |
39 000 |
|
Immune status |
||
|
Alpha interferon in the blood |
1 test |
10 920 |
|
Gamma interferon in the blood |
1 test |
10 920 |
|
Secretory immunoglobulin A in blood serum (sIgA) |
1 test |
6 565 |
|
Total Immunoglobulin E (total IgE) |
1 test |
7 280 |
|
Immunophenotyping of HLA B27 in blood using flow cytometry |
1 test |
35 750 |
|
Interleukin-10 |
1 test |
8 905 |
|
Interleukin-2 |
1 test |
10 920 |
|
Interleukin-6 |
1 test |
13 260 |
|
Interleukin-8 |
1 test |
8 905 |
|
Interleukin - 13 (IL-13) in serum and blood plasma |
1 test |
23 920 |
|
Interleukin - 3 (IL-3) in serum and blood plasma |
1 test |
42 315 |
|
Interleukin - 5 (IL-5) in serum and blood plasma |
1 test |
23 920 |
|
Interleukin - 1 beta (IL-1-beta, IL-1-β) in human biological fluids and culture media by ELISA method, quantitation |
1 test |
12 025 |
|
Interleukin - 13 (IL-13, IL-13) in blood serum by ELISA method, quantitation |
1 test |
13 000 |
|
Interleukin - 18 (IL-18, IL-18) in blood serum by ELISA method, quantitation |
1 test |
10 400 |
|
Interleukin - 3 (IL-3, IL-3) in blood serum by ELISA method, quantitation |
1 test |
13 000 |
|
Interleukin - 4 (IL-4, IL-4) in blood serum by ELISA method, quantitation |
1 test |
10 660 |
|
Interleukin - 5 (IL-5, IL-5) in blood serum by ELISA method, quantitation |
1 test |
13 000 |
|
Eosinophil cationic protein (ECP) |
1 test |
12 285 |
|
Tryptase |
1 test |
10 660 |
|
Serological markers of coronavirus infection SARS-CoV-2 (COVID-19, 2019-nCoV) |
||
|
IgM antibodies to SARS-CoV-2 (qualitative) |
1 test |
5 915 |
|
IgG antibodies to SARS-CoV-2 (qualitative) |
1 test |
5 980 |
|
nCoV antibodies - Nab (post-vaccination, quantitative) |
1 test |
6 825 |
|
Immunoglobulin G to SARS-CoV-2 (quantitative) |
1 test |
6 825 |
|
Immunoglobulin M to SARS-CoV-2 (quantitative) |
1 test |
8 190 |
|
IgG/IgM antibodies to SARS-CoV-2 (Rapid test) (qualitative) |
1 test |
8 905 |
|
Sars-CoV-2 specific antigen (rapid test) (qualitative) |
1 test |
7 410 |
|
Drug monitoring |
||
|
Tacrolimus in blood serum by immunochemiluminescence |
1 test |
13 130 |
|
Markers of sepsis |
||
|
Procalcitonin, PCT (quantitation by enzyme immunoassay) |
1 test |
13 650 |
|
Procalcitonin, PCT (quantitation by immunofluorescence method) |
1 test |
11 895 |
|
Bone metabolism |
||
|
Osteocalcin (N-MID Osteocalcin) |
1 test |
8 190 |
|
Parathyroid hormone (PTH) |
1 test |
7 800 |
|
Pyrilinks-D (DPD) |
1 test |
4 940 |
|
Tumor markers |
||
|
Alpha 1-fetoprotein (AFP) |
1 test |
4 940 |
|
Squamous cell carcinoma antigen (SCC-Ag) |
1 test |
5 330 |
|
Calcitonin |
1 test |
11 635 |
|
Neuron - specific enolase (NSE, NSE) in blood serum by immunochemiluminescence |
1 test |
8 190 |
|
Progastrin releasing peptide (ProGRP) |
1 test |
7 280 |
|
Prostate-specific antigen total (PSA total, PSA total) |
1 test |
4 420 |
|
Prostate-specific antigen free (PSA free) |
1 test |
4 810 |
|
Carcinoembryonic antigen (CEA, CEA) |
1 test |
5 070 |
|
Cancer antigen 72-4 (CA 72-4) |
1 test |
8 905 |
|
Cancer antigen 125 (CA 125) |
1 test |
5 785 |
|
Cancer antigen 15-3 (CA 15-3) |
1 test |
5 330 |
|
Cancer antigen 19-9 (CA 19-9) |
1 test |
5 785 |
|
Cancer antigen 242 (CA 242) |
1 test |
11 245 |
|
Tumor necrosis factor-alpha (TNF-α, α-TNF) |
1 test |
7 540 |
|
Cytokeratin fragment 19 (Cyfra21-1) |
1 test |
7 540 |
|
Human chorionic gonadotropin intact + beta subunit (HCG+beta) |
1 test |
7 540 |
|
Total human chorionic gonadotropin in urine (HCG urine) |
1 test |
6 175 |
|
Total human chorionic gonadotropin (HCG) |
1 test |
3 250 |
|
Human epididymal protein 4 (HE4) |
1 test |
8 905 |
|
Other tests |
||
|
Homocysteine (Hcy-SH) |
1 test |
9 100 |
|
Erythropoietin (EPO) |
1 test |
5 915 |
|
Pancreatic elastase content in feces |
1 test |
20 475 |
|
Serological markers of brucellosis |
||
| Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to mumps virus in serum/plasma | ||
| Mumps IgG (Enzyme immunoassay for the detection of Immunoglobulin G antibodies to mumps virus in serum/plasma) | 1 test | 4 550 |
| Mumps IgM (Enzyme immunoassay for the detection of Immunoglobulin M antibodies to mumps virus in serum/plasma) | 1 test | 4 550 |
|
Class A antibodies to the causative agent of brucellosis |
1 test |
5 460 |
|
Class G antibodies to the causative agent of brucellosis |
1 test |
5 460 |
|
Class M antibodies to the causative agent of brucellosis |
1 test |
5 460 |
|
Serological markers of viral hepatitis D |
||
|
Total class M, G antibodies to hepatitis D virus (a-HDV total) |
1 test |
4 095 |
|
Serological markers of viral hepatitis A |
||
|
Class M antibodies to hepatitis A virus (a-HAV IgM) |
1 test |
3 315 |
|
Serological markers of viral hepatitis B |
||
|
Hepatitis B virus "e" antigen (HBeAg) |
1 test |
3 510 |
|
Class G antibodies to the “e” antigen of the hepatitis B virus (a-HBeAg IgG) |
1 test |
3 185 |
|
Antibodies class G to the nuclear antigen of the hepatitis B virus (a-HBcAg IgG) |
1 test |
3 705 |
|
Antibodies class M to the nuclear antigen of the hepatitis B virus (a-HBcAg IgM) |
1 test |
3 575 |
|
Hepatitis B surface antigen (HBsAg, Australian antigen) |
1 test |
3 315 |
|
Total antibodies class M, G to the “e” antigen of the hepatitis B virus (a-HBeAg total) |
1 test |
3 575 |
|
Total antibodies class M, G to the surface antigen of the hepatitis B virus (a-HBsAg total) |
1 test |
3 965 |
|
Total antibodies class M, G to the nuclear antigen of the hepatitis B virus (a-HBcAg total) |
1 test |
4 420 |
|
НBsAg, Rapid test (Hepatitis B surface antigen, qualitation) |
1 test |
2 470 |
|
Serological markers of viral hepatitis C |
||
|
Hepatitis C virus antigen (HCV Ag) |
1 test |
11 635 |
|
Antibodies class M to hepatitis C virus (HCV IgM) |
1 test |
4 810 |
|
Total antibodies class M, G to hepatitis C virus (a-HCV total) |
1 test |
3 965 |
|
a-HCV, Rapid test (Specific antibodies to hepatitis C virus, qualitation) |
1 test |
2 600 |
|
Serological markers of HIV infection |
||
|
HIV p24 antigen and antibodies to human immunodeficiency virus types 1, 2 (HIV-1/2, HIV-1/2) |
1 test |
4 095 |
|
Immunochromatic rapid test of the third generation for the determination of antibodies to human immunodeficiency virus types 1 and 2 (a-HIV-1/2) |
1 test |
2 730 |
|
Express test for determining the free antigen HIV-1 p24 antibodies and antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) |
1 test |
4 420 |
|
ELISA for the presence of antibodies to the human immunodeficiency virus (HIV, AIDS center) |
1 test |
3 445 |
|
Serological markers of herpes infection |
||
|
Class G antibodies to herpes simplex virus type 8 (HSV-8-IgG) |
1 test |
3 705 |
|
Class G antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgG) |
1 test |
4 095 |
|
Class G antibodies to herpes simplex virus type 1 (HSV-1-IgG) |
1 test |
2 990 |
|
Class G antibodies to herpes simplex virus type 2 (HSV-2-IgG) |
1 test |
3 835 |
|
Antibodies class G to herpes simplex virus type 6, (HHV-6-IgG) |
1 test |
4 095 |
|
Class M antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgM) |
1 test |
3 835 |
|
Class M antibodies to herpes simplex virus type 2 (HSV-2-IgM) |
1 test |
4 550 |
|
Antibodies class M to herpes simplex virus type 1 (HSV-1-IgM) |
1 test |
3 445 |
|
Avidity index of class G antibodies to herpes simplex virus types 1 and 2 (HSV–1,2-IgG–Avidity) |
1 test |
4 290 |
|
Avidity index of class G antibodies to herpes simplex virus type 2 (HSV–2-IgG–Avidity) |
1 test |
4 290 |
|
Serological markers of infectious mononucleosis |
||
|
Class G antibodies to Epstein-Barr virus early antigen (EBV-EA IgG) |
1 test |
4 420 |
|
Class G antibodies to Epstein-Barr virus nuclear antigen (EBV-NA IgG) |
1 test |
4 420 |
|
Class G antibodies to Epstein-Barr virus capsid antigen (EBV-VCA IgG) |
1 test |
4 420 |
|
Antibodies class M to Epstein-Barr virus capsid antigen (EBV-VCA IgM) |
1 test |
4 420 |
|
Index of avidity of class G antibodies to the capsid antigen of the Epstein-Barr virus (EBV-VCA IgG-Avidity) |
1 test |
4 810 |
|
Serological markers of rubella |
||
|
Class G antibodies to rubella virus (Rubella IgG) |
1 test |
3 575 |
|
Class M antibodies to rubella virus (Rubella IgM) |
1 test |
3 835 |
|
Avidity index of class G antibodies to rubella virus (Rubella IgG-Avidity) |
1 test |
4 420 |
|
Serological markers of listeriosis |
||
|
Class G antibodies to Listeria monocytogenes |
1 test |
3 055 |
|
Serological markers of cytomegalovirus infection |
||
|
Antibodies of class G and M to the immediate early protein of cytomegalovirus (CMV-IEA-IgG/M) |
1 test |
4 940 |
|
Antibodies class G to cytomegalovirus (CMV IgG) |
1 test |
5 070 |
|
Antibodies class M to cytomegalovirus (CMV IgM) |
1 test |
4 940 |
|
Index of avidity of class G antibodies to cytomegalovirus (CMV-IgG-Avidity) |
1 test |
4 810 |
|
Serological markers. Antibodies to protozoa, parasites and fungi |
||
|
Class G antibodies to fungi of the genus Candida albicans (Candida albicans IgG) |
1 test |
4 810 |
|
Class A antibodies to Trichomonas (Trichomonas vaginalis IgA) |
1 test |
4 810 |
|
Class G antibodies to Ascaris antigens (Ascaris lumbricoides IgG) |
1 test |
4 810 |
|
Class G antibodies to Aspergillus antigens (Aspergillus IgG) |
1 test |
4 810 |
|
Class G antibodies to Opisthorchis antigens (a-Opistorhide IgG) |
1 test |
4 810 |
|
Class G antibodies to Toxocara antigens (a-Toxocara IgG) |
1 test |
4 810 |
|
Class G antibodies to Trichinella antigens (a-Trichinella IgG) |
1 test |
4 810 |
|
Class G antibodies to Echinococcus unilocular antigens (a-Echinococcus IgG) |
1 test |
4 810 |
|
Class G antibodies to Toxoplasma (Toxoplasma gondii IgG) |
1 test |
4 810 |
|
Class G antibodies to Trichomonas (Trichomonas vaginalis IgG) |
1 test |
4 810 |
|
Class A antibodies to Toxoplasma (Toxoplasma gondii IgA) |
1 test |
4 810 |
|
Class M antibodies to Toxoplasma (Toxoplasma gondii IgM) |
1 test |
4 810 |
|
Avidity index of class G antibodies to Toxoplasma (Toxoplasma gondii IgG–Avidity) |
1 test |
3 965 |
|
Specific circulating immunocomplexes (CICs) containing opisthorchis antigens |
1 test |
5 200 |
|
Total antibodies of class A, M, G to lamblia (a-Lamblia total) |
1 test |
4 095 |
| Giardia IgM (Enzyme immunoassay for the detection of Immunoglobulin M antibodies to Giardia antigens in serum/plasma) | 1 test | 3 770 |
|
Serological markers. Bacterial antibodies |
||
|
Class A antibodies to mycoplasma (Mycoplasma hominis IgA) |
1 test |
4 095 |
|
Class A antibodies to ureaplasma (Ureaplasma urealyticum IgA) |
1 test |
4 095 |
|
Class G antibodies to ureaplasma (Ureaplasma urealyticum IgG) |
1 test |
4 095 |
|
Class G antibodies to Helycobacter pylori |
1 test |
4 745 |
|
Class G antibodies to Chlamydia trachomatis heat shock protein (HSP60), diagnosis of early infection |
1 test |
3 055 |
|
Class G antibodies to major outer membrane protein (MOMP) and plasmid protein pgp3 of Chlamydia trachomatis |
1 test |
3 575 |
|
Class G antibodies to mycoplasma (Mycoplasma hominis IgG) |
1 test |
4 095 |
|
Class G antibodies to chlamydia (Chlamydia trachomatis IgG) |
1 test |
4 095 |
|
Class M antibodies to chlamydia (Chlamydia trachomatis IgM) |
1 test |
4 095 |
|
Class A antibodies to chlamydia (Chlamydia trachomatis IgA) |
1 test |
4 095 |
|
Total antibodies class A, M, G to the Cag antigen of Helycobacter pylori |
1 test |
4 095 |
|
Total antibodies class A, M, G to Mycobacterium tuberculosis (a-Mycobacterium Tuberculosis) |
1 test |
4 420 |
|
Total antibodies class A, M, G to syphilis (Treponema pallidum total) |
1 test |
4 420 |
|
Specific blood proteins |
||
|
N-terminal pro-brain B-type natriuretic peptide (NT-pro BNP) |
1 test |
22 555 |
|
Troponin I (TNI), quantitation |
1 test |
10 140 |
|
Troponin I high sensitivity (TNI), quantitation |
1 test |
11 895 |
|
Rapid test for the qualitation of Troponin I (TNI) and myoglobin |
1 test |
3 250 |
|
Brain natriuretic peptide (BNP) |
1 test |
27 300 |
| Urinary specific proteins | ||
|
Neutrophil gelatinase-associated lipocalin, NGAL |
1 test |
8 775 |
|
Microbiological testings |
||
|
Bacteriological testings |
||
|
Bacteriological examination of autopsy material |
1 test |
8 905 |
|
Bacteriological examination of biomaterial from the nose for staphylococcus |
1 test |
7 540 |
|
Bacteriological examination of biomaterial for anaerobes |
1 test |
7 800 |
|
Bacteriological examination of biomaterial for yersiniosis |
1 test |
7 540 |
|
Bacteriological examination of biomaterial for meningococcus |
1 test |
9 555 |
|
Bacteriological examination of biomaterial for microflora |
1 test |
12 285 |
|
Bacteriological examination of biomaterial for the presence of the causative agent of diphtheria |
1 test |
8 905 |
|
Bacteriological examination of biomaterial for the presence of fungi with identification of their species |
1 test |
8 645 |
|
Bacteriological examination of stool for cholera (form 30) |
1 test |
8 905 |
|
Bacteriological blood test for sterility using a bacteriological analyzer |
1 test |
11 505 |
|
Bacteriological test for group B streptococcus (GBS) |
1 test |
19 825 |
|
Taking biomaterial for microbiological research |
1 test |
1 690 |
|
Test for intestinal dysbiosis |
1 test |
19 110 |
|
Bacteriological examination of feces for pathogenic and opportunistic intestinal microflora with sensitivity determination |
1 test |
7 150 |
|
Identification of a pure culture of a microorganism using mass spectrometry |
1 test |
2 925 |
|
Bacteriological examination of biomaterial for meningococcus PASTOREX MENINGITIS |
1 test |
30 030 |
|
Bacteriological examination of genital secretions using the Genital SYSTEM method |
1 test |
20 475 |
|
Gene-Xpert Determination of M. tuberculosis and rifampicin resistance |
1 test |
50 505 |
|
Sanitary and bacteriological testings |
||
|
Bacteriological air testing (1 room) |
1 test |
2 925 |
|
Bacteriological examination of liquid dosage forms and material for sterility (10 samples) |
1 test |
4 550 |
|
Bacteriological testing swabs from environmental objects for coliform bacteria (coliforms), pathogenic intestinal flora, golden staff |
1 test |
2 080 |
|
Sputum examinations |
||
|
Microscopic examination of biomaterial for the presence of acid-fast bacteria (AFB) for suspected tuberculosis |
1 test |
3 315 |
|
Parasitological examination of stool |
||
|
Examination of stool for helminth eggs using a fecal parasite concentrator |
1 test |
3 445 |
|
Examination of stool for protozoa and helminth eggs |
1 test |
2 210 |
|
Serological diagnosis of syphilis |
||
|
Microreaction |
1 test |
1 755 |
|
Wasserman reaction (RW) |
1 test |
5 070 |
|
Syphilis, Rapid test (Specific antibodies to Treponema pallidum, qualitative determination) |
1 test |
4 680 |
|
Molecular biological research (PCR) |
||
|
PCR based bacterial infections diagnostics |
||
|
Brucella DNA (DNA Brucella species) |
1 test |
6 825 |
|
DNA of the causative agent of respiratory mycoplasmosis/chlamydia (Mycoplasma pneumoniae/Chlamydophila pneumoniae DNA) |
1 test |
8 515 |
|
Mycobacterium tuberculosis DNA (Mucobacterium tuberculosis DNA) |
1 test |
4 940 |
|
Toxoplasma gondii DNA |
1 test |
4 810 |
|
PCR based viral hepatitis diagnostics |
||
|
Hepatitis C virus genotyping: 1a, 1b, 2, 3a, 4b genotypes (HCV Genotype, HCV Genotyping/Subtyping) Genotyping/Subtyping) |
1 test |
17 225 |
|
Hepatitis B virus DNA, qualitaion (HBV DNA Qualitative) |
1 test |
11 635 |
|
Hepatitis B virus DNA, quantitation (HBV DNA viral load, HBV DNA Quant.) |
1 test |
16 120 |
|
Hepatitis D virus RNA, qualitation (HDV RNA Qualitative) |
1 test |
13 000 |
|
Hepatitis C virus RNA quantitation (HCV RNA viral load, HCV RNA Quant.) |
1 test |
18 070 |
|
Hepatitis C virus RNA, qualitation (HCV RNA, RNA HCV Qualitative) |
1 test |
12 740 |
|
PCR based viral infections diagnostics |
||
|
PCR based diagnostics of the COVID-19 virus |
1 test |
10 270 |
|
DNA cytomegalovirus (DNA Cytomegalovirus Quant), quantitation) |
1 test |
13 650 |
|
DNA of Gardnerella and others (Florocenosis/bacterial vaginosis) quantitation |
1 test |
6 435 |
|
Human papillomavirus DNA of high carcinogenic risk, screening (HPV DNA, high-risk HPV DNA) |
1 test |
14 365 |
|
Varicella-Zoster virus DNA (VZV DNA, DNA Varicella-Zoster virus, DNA VZV) |
1 test |
3 445 |
|
DNA Rubella virus (DNA Rubella virus) |
1 test |
3 575 |
|
Human papillomavirus DNA 16/18 types (HPV DNA 16/18, DNA НРV 16/18) |
1 test |
8 190 |
|
DNA of herpes simplex virus types 1 and 2 (DNA HSV 1, 2) |
1 test |
8 190 |
|
Epstein-Barr virus DNA (DNA EBV Qualitative), qualitation |
1 test |
4 095 |
|
Epstein-Barr virus DNA (EBV DNA, DNA EBV Quant), quantitation) |
1 test |
8 190 |
|
DNA of ARVI pathogens |
1 test |
8 905 |
|
DNA cytomegalovirus (DNA Cytomegalovirus) |
1 test |
10 270 |
|
Detection of the DNA of the causative agent of pertussis |
1 test |
7 150 |
|
Detection of the DNA of the causative agent of pneumocysosis |
1 test |
6 825 |
|
Detection of human metapneumovirus RNA and human parainfluenza virus type 2 RNA |
1 test |
17 745 |
|
PCR based urogenital infections diagnostics |
||
|
DNA of ureaplasma and mycoplasma (Florocenosis/ureaplasma, mycoplasma) (quantitation) |
1 test |
6 305 |
|
Candida DNA (Florocenosis/Candida) (quantitation) |
1 test |
6 175 |
|
Candida albicans DNA |
1 test |
5 070 |
|
Chlamydia trachomatis DNA |
1 test |
5 070 |
|
Gardnerella vaginalis DNA |
1 test |
5 070 |
|
Mycoplasma genitalum DNA |
1 test |
5 070 |
|
Mycoplasma hominis DNA |
1 test |
5 070 |
|
Neisseria gonorrhoeae DNA |
1 test |
5 070 |
|
Trichomonas vaginalis DNA |
1 test |
5 070 |
|
Ureaplasma species DNA |
1 test |
5 070 |
|
PCR based other infections diagnostics |
||
|
DNA of helminthiasis pathogens (Ascaris lumbricoides, Enterobius vermicularis, Opisthorchis felineus, Taenia solium, Diphyllobothrium latum) |
1 test |
10 335 |
|
DNA from pathogens of protozoal infections (Lamblia Intestinalis Giardia, Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium parvum, Entamoeba histolytica) |
1 test |
10 335 |
|
General clinical studies |
||
|
General clinical stool examinations |
||
|
Examination of feces for occult blood |
1 test |
3 055 |
|
Test for Helicobacter pylori antigen (qualitation, rapid test) |
1 test |
5 785 |
|
Calprotectin (qualitation, rapid test) |
1 test |
8 905 |
|
Calprotectin (quantitation by enzyme immunoassay) |
1 test |
16 640 |
|
Coprogram |
1 test |
4 095 |
| Automated Coprogram | 1 test | 4 160 |
|
General clinical urine tests |
||
|
Protein in daily urine |
1 test |
2 340 |
|
Urinalysis according to Nechiporenko |
1 test |
2 730 |
|
Daily urinу analysis according to Zimnitsky |
1 test |
2 730 |
|
Microalbumin (MAU) in a single portion of urine (semi-quantitative determination) |
1 test |
1 365 |
|
General sputum analysis |
1 test |
2 730 |
|
General urinalysis (UCA) |
1 test |
1 950 |
|
Rhinocytogram (cellular composition) |
1 test |
3 055 |
|
Three-glass urine sample |
1 test |
1 820 |
| Automated Urinalysis | 1 test | 2 210 |
|
Сlinical examinations of urethral and vaginal discharge |
||
|
Microscopic examination of urethral discharge (urethral smear) |
1 test |
3 185 |
|
Microscopic examination of prostate secretion (prostate gland) |
1 test |
3 185 |
|
Determining the degree of purity of a gynecological smear |
1 test |
4 095 |
|
Spermogram with determination of sperm morphology |
1 test |
11 635 |
|
MAR test |
1 test |
10 270 |
|
Сlinical examinations of other biomaterial |
||
|
Biomaterial examination for the genus Demodex (Demodex) |
1 test |
2 730 |
|
Biomaterial examination for the pathogenic fungi |
1 test |
2 340 |
|
Clinical examination of cerebrospinal fluid (CSF, cerebrospinal fluid) |
1 test |
1 690 |
|
Clinical examination of duodenal contents (bile) |
1 test |
3 835 |
|
Clinical examination of serous cavities fluids and cysts (exudate, transudate) |
1 test |
1 820 |
|
Microscopic examination of a smear stained according to Romanovsky |
1 test |
2 600 |
|
Microscopic examination of skin scrapings for the scabies mites. |
1 test |
2 730 |
|
Genomic laboratory services |
||
|
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 52 key genes connected with canceration, pan |
1 test |
614 250 |
|
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 69 key genes connected with the development of myeloid disorders |
1 test |
655 200 |
|
Molecular genetic diagnosis of V600E mutations in the BRAF gene from tumor cells enclosed in paraffin sections |
1 test |
90 740 |
|
Molecular genetic diagnosis of mutations in the ALK gene from tumor cells enclosed in paraffin sections |
1 test |
61 425 |
|
Whole exome sequencing of human DNA to search for a presumably hereditary disease with interpretation of the results |
1 test |
1 501 500 |
|
Mutations in HLA CLASS II genes - DQ2, DQ8, DQA1*05 in celiac disease using real-time PCR |
1 test |
122 850 |
|
FISH diagnostics of bone marrow cells to identify the chimeric gene BCR/ABL t(9;22), in CML and ALLrh+ |
1 test |
68 380 |
|
FISH diagnosis of bladder cancer to detect aneuploidy of chromosomes 3, 7, 17 and deletion of the 9p21 locus |
1 test |
101 010 |
|
FISH diagnosis of numerical chromosomal pathologies 13, 18, 21, X and Y in amniotic fluid |
1 test |
80 535 |
|
Qualitation of the chimeric gene BCR/ABL-t(9;22) using real-time PCR |
1 test |
21 840 |
|
Quantitative determination of the BCR/ABL-t(9;22) chimeric gene using real-time PCR |
1 test |
36 855 |
|
Molecular genetic diagnosis using MLPA method of large deletions/duplications in the SMN1 and SMN2 genes associated with spinal muscular atrophy |
1 test |
96 265 |
|
Minimal residual disease |
1 test |
36 855 |
|
Mutation in the DMD gene in Duchenne muscular dystrophy using the MLPA method |
1 test |
96 265 |
|
Standard cytogenetic research (karyotyping) of peripheral blood cells |
1 test |
40 950 |
|
Molecular genetic analysis (genotyping) of mutations in genes associated with the risk of arterial hypertension and diabetes mellitus 2 s |
1 test |
81 575 |
|
Molecular genetic diagnosis of V617F mutations in the JAK2 gene in myeloproliferative diseases |
1 test |
36 855 |
|
Molecular genetic assessing the ratios of human microorganisms (microbiome) |
1 test |
227 955 |
|
Molecular genetic prenatal diagnosis of amniotic fluid cells for aneuploidy of chromosomes 13, 18, 21, X, Y |
1 test |
76 440 |
|
Molecular genetic analysis of mutations in 12 genes associated with epidermolysis bullosa |
1 test |
238 875 |
|
Molecular genetic analysis of sensitivity to imatinib for patients with the Ph chromosome in CML and ALLPh+ |
1 test |
39 585 |
|
Molecular genetic diagnosis of polymorphism for susceptibility genes PNPLA3 and TM6SF2 in non-alcoholic steatohepatitis |
1 test |
19 435 |
|
Mutations in the BRCA gene Oncomine Research Assay |
1 test |
435 435 |
|
Mutations, chimeric transcripts and copy number variants in 161 genes associated with canceration, ONCOMINE Comprehensive ASSAY panel |
1 test |
600 600 |
|
Genealogical origin by Y chromosome |
1 test |
107 185 |
|
Mutations in the FLT3 gene (ITD, TKD - D835F) by molecular genetic method |
1 test |
43 680 |
|
JAK2 gene mutations in exon 12 by MLPA method (fragment analysis) |
1 test |
61 425 |
|
Mutation in the PIK3CA gene using a molecular genetic method |
1 test |
61 425 |
|
Mutations in the CFTR gene in cystic fibrosis |
1 test |
97 630 |
|
Individual sensitivity to warfarin |
1 test |
51 220 |
|
Microdeletions (fragment analysis) using the MLPA method for delayed psychomotor development |
1 test |
96 265 |
|
Genotyping in Amyotrophic Lateral Sclerosis |
1 test |
58 695 |
|
Mutations in the KRAS gene |
1 test |
137 865 |
|
Molecular genetic analysis for microsatellite instability (MSI) |
1 test |
155 610 |
|
Fetal Rh factor in maternal blood |
1 test |
63 505 |
|
Mutations in freely circulating tumor DNA |
1 test |
819 000 |
|
Mutations in the NF1 gene in neurofibromatosis using the MLPA method |
1 test |
294 840 |
|
Chimeric gene KIAA-BRAF, BRAF V600E by MLPA |
1 test |
122 850 |
|
ERBB2 (HER2) gene amplification |
1 test |
109 200 |
|
Non-invasive prenatal testing for the risk of aneuploidies (chromosomes 13,18,21) |
1 test |
204 750 |
|
Determination of CD274 (PD-L1) gene amplification |
1 test |
120 120 |
|
Detection of SMN1 and SMN2 gene mutations using PCR |
1 test |
8 905 |
|
HPV genotyping by sequencing |
1 test |
81 900 |
|
Gene sequencing for hereditary diseases using NGS (Next-Generation Sequencing) |
1 test |
573 300 |
|
Gliomas diagnostics |
||
|
Detection of aberrant methylation (MGMT) |
1 test |
62 140 |
|
Detection of mutations in the IDH1 and IDH2 genes |
1 test |
62 140 |
|
Detection of WNT and SHH pathway activation mutations |
1 test |
85 345 |
|
Detection of mutations in the CDKN2A/2B genes |
1 test |
62 140 |
|
Detection of mutations in the EGFR gene |
1 test |
62 140 |
|
Detection of mutations in the ATRX gene |
1 test |
62 140 |
|
Detection of mutations in the TP53 gene |
1 test |
62 140 |
|
Detection of 1p/19q co-expression |
1 test |
62 140 |
|
Detection of H3K27 mutation |
1 test |
143 325 |
|
Detection of mutations in the MYCN gene |
1 test |
62 140 |
|
Detection of RELA fusion mutation |
1 test |
124 930 |
|
C19MC gene, miRNA profiling |
1 test |
48 490 |
|
Detection of mutations in the VEGF gene |
1 test |
57 330 |
|
“Glioma” panel (Mutation status of tumor cells in gliomas |
1 test |
586 950 |
|
Detection of mutations in the FGFR gene |
1 test |
81 900 |